Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.36 | 7e-27 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.36 | 3e-26 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-22 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.4 | 7e-19 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.4 | 7e-15 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-14 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.34 | 8e-12 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |